SUMMARY
PHENDIMETRAZINE TARTRATE TABLETS, USP 35 mg
Phendimetrazine tartrate, as the dextro isomer, has the chemical name of (2S,3S)-3,4-dimethyl-2-phenylmorpholine L-(+)-tartrate (1:1).
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
Phendimetrazine tartrate is indicated for use as monotherapy only.
|
NEWS HIGHLIGHTSMedia Articles Related to Phendimetrazine
AHA: Obesity and Smoking Major Risk Factors for VTE (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2009.11.19]
ORLANDO (MedPage Today) -- Overweight smokers have the greatest risk of a venous thrombotic event, according to a review of data from the Copenhagen City Heart Study reported here.
AHA: Obesity Okay with Some People (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2009.11.19]
ORLANDO (MedPage Today) -- Nearly one obese person in 10 feels no need to lose weight or prevent further weight gain, researchers found.
Appalachia, Southeast Hit Hardest by Obesity and Diabetes (HealthDay)
Source: Y! Health Diabetes News [2009.11.19]
HealthDay - THURSDAY, Nov. 19 (HealthDay News) -- While rates of obesity are
climbing across America, they are especially high in sections of
Appalachia and the Southeast, the U.S. Centers for Disease Control and
Prevention reports in its first county-by-county survey.
Increased Obesity Hindering Success At Reducing Heart Disease Risk
Source: Cholesterol News From Medical News Today [2009.11.18]
The dramatic increase in overweight and obesity in adult Americans over the past 20 years has undermined public health success at reducing risk for heart disease, according to research presented at the American Heart Association's Scientific Sessions 2009. In a new study, researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 1988-2006, representing 8,264 adult men and women, 20 to 85 years old.
Obesity Rates Will Continue To Increase, Drive Health Care Costs In Pennsylvania Over Next Decade, According To New Study
Source: Obesity / Weight Loss / Fitness News From Medical News Today [2009.11.18]
A new report released based on research by Emory University Health Care Economist Ken Thorpe, Ph.D., Executive Director of the Partnership to Fight Chronic Disease (PFCD), shows increasing obesity rates in Pennsylvania and across the country will result in higher health care spending for states and individuals.
|
|
|
|
Page last updated: 2009-11-19
|
